Is a third-trimester antibody screen in Rh+ women necessary?

American Journal of Managed Care

Volumn 5, Issue 9, 1999, Pages 1145-1150

  Rothenberg, Jeffrey M ^a   Weirermiller, Beata ^b   Dirig, Kelly ^c   Hurd, William W ^a   Schilder, Jeanne ^a   Golichowski, Alan ^a  

^a INDIANA UNIVERSITY   (United States)

^b Providence Medical Center   (United States)

^c Providence Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN HEMOLYTIC DISEASE; OUTCOMES RESEARCH; PERIODIC MEDICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; RHESUS INCOMPATIBILITY; SCREENING TEST; SENSITIZATION; THIRD TRIMESTER PREGNANCY;

AUTOANTIBODIES; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; DATA COLLECTION; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEALTH SERVICES RESEARCH; HOSPITALS, TEACHING; HUMANS; INDIANA; MEDICAL AUDIT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RH-HR BLOOD-GROUP SYSTEM; UNNECESSARY PROCEDURES;

EID: 0032873402     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chavez CF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991;265:3270-3274.
2. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: A continuing problem. Clin Obstet Gynecol 1982;25:321-332.
3. Weinstein L, Taylor ST. Hemolytic disease of the neonate secondary to anti-Fya. Am J Obstet Gynecol 1975;121:643-645.
4. Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without excessive elevation of the Delta OD. 450 value in amniotic fluid. Obstet Gynecol 1982;60:746-749.
5. Solola A, Sibai B, Mason JM. Irregular antibodies: An assessment of routine prenatal screening. Obstet Gynecol 1983;61:25-30.
6. Queenan JT, Smith BD, Haber JM, Jeffrey J, Gadow HC. Irregular antibodies in the obstetric patient. Obstet Gynecol 1969;34:767-770.
7. Bowman HS. Prenatal serodiagnosis of blood group sensitization. Am J Obstet Gynecol 1968;101:614-622.
8. Prevention of Isoimmunization. American College of Obstetricians and Gynecologists Technical Bulletin #147. Elk Grove Village, IL: American College of Obstetricians and Gynecologists;1990.
9. Pepperell RJ, Barrie JU, Fliegner JR. Significance of red-cell irregular antibodies in the obstetric patient. Med J Aust 1977;45:453-456.
10. Filbey D, Hansen ULF, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: A 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995;4:687-692.
11. Bowman J. Hemolytic disease. In: Creasy R, Resnik R, eds. Maternal-Fetal Medicine. Philadelphia, PA: WB Saunders; 1994:711-743.
12. Freeman RK, Poland RL, eds. Guidelines for Perinatal Care, 3rd ed. Elk Grove Village, IL: American Association of Pediatrics/American College of Obstetricians and Gynecologists; 1992.
13. Miller WV, ed. Technical Manual of the American Association of Blood Banks, 7th ed. Philadelphia, PA: JB Lippincott;1977:166-187.
14. Feldman R, Luhby LA, Gromisch DS. Erythroblastosis fetal is due to anti-S antibody. J Pediatr 1973;82:88-91.
15. Moise KJ. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med 1994;118:421-428.
16. McDonald CJ, Tierney WM, Overhage JM, Martin DK, Wilson GA. The Regenstrief Medical Record System: 20 years of experience in hospitals, clinics, and neighborhood health centers. MD Computing 1992;9:206-217.
17. Walker RH. Relevancy in the selection of serologic tests for the obstetric patient. In: Garraty G, ed. Hemolytic Disease of the Newborn. Washington, DC: American Association of Blood Banks;1984:173-200.
18. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn. Obstet Gynecol Surv 1976;31:581-591.
19. Schumacher B, Moise KJ. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-150.
20. Giblett ER. Blood group antibodies: An assessment of some laboratory practices. Transfusion 1977;17:299-308.
21. Moise KJ. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med 1994;18:421-428.
22. Pirofsky B. Erythroblastosis - a changing serologic problem. Am J Obstet Gynecol 1963;92:720-726.